You are here

Nerve Ablation Device Gets 501(k) Clearance for Chronic Pain

Minimally Invasive Procedure Uses Radio Waves to Thwart Pain

Medtronic has received FDA clearance for its Accurian radio-frequency ablation system for nerve tissues; the device is designed to treat chronic pain via a minimally invasive procedure.

A current produced by radio waves heats up small patches of nerves to stop them from sending pain signals. The system also uses advanced software that controls the amount of power delivered and the temperature of the procedure, ensuring more consistent and predictable lesion formations.

Medtronic says that its Accurian platform can perform standard, pulsed, and enhanced ablation procedures, using internally cooled radio frequency probes to create various lesion shapes, sizes, and volumes. It has independent channel control and chip-enhanced probes for easy on-screen identification, and smart features, such as downloadable procedure reports.

Chronic pain is a disabling condition that affects approximately 100 million American adults. The annual treatment cost of chronic pain and related lost productivity is estimated to be $635 billion.

Source: FierceBiotech, February 27, 2019; Medtronic, February 27, 2019

More Headlines

First and Only Treatment Reduces Depressive Symptoms Within Days
Bone Marrow Cleared of Leukemia in Almost 60% of Patients
Combination of Two Drugs Could Reduce Tumor Growth
Atezolizumab in Combination with Chemotherapy is the Only First-line Cancer Immunotherapy for ES-SCLC
Pre-clinical Trials Showed Drug Inhibits Fibroblast Activity and Collagen Deposition
PARG Inhibitor Exploits Weakness, Kills Cells
Inexpensive, Wearable Therapy Increases Arm Mobility, Reduces Stiffness
National Statistics Report Factors In Race, Ethnicity for the First Time